Codal Synto


Concise Prescribing Info
Bromocriptine mesylate
Inhibition or suppression of puerperal lactation. Treatment of hyperprolactinaemia in men & women w/ hypogonadism &/or galactorrhoea; hyperprolactinaemic infertility; infertile women who do not have demonstrable hyperprolactinaemia; patient w/ prolactin secreting adenoma; patient w/ macroadenomas & as an alternative to surgical procedure in patient w/ microadenomas; cyclical benign breast diseases/cyclical pronounced mastalgia; cyclical menstrual disorders & treatment of symptoms in premenstrual syndrome; acromegaly, idiopathic Parkinson's disease.
Dosage/Direction for Use
Initially 1.25 mg increased after 2-3 days to 2.5 mg at bedtime. Dosage may be increased by 1.25 mg at 2-3 days interval until 2.5 mg bd is reached. Further dosage increments, if necessary, should be effected in a similar manner. Prevention of lactation 2.5 mg on day of delivery followed by 2.5 mg bd for 14 days. Suppression of lactation 2.5 mg on 1st day, increasing after 2-3 days to 2.5 mg bd for 14 days. Hypogonadism/prolactinomas/galactorrhoea syndrome/infertility 7.5-30 mg daily in divided doses. Cyclical benign breast disease/cyclical pronounced mastalgia/cyclical menstrual disorders 2.5 mg bd. Acromegaly 20-60 mg. Parkinson's disease 10-80 mg daily in divided doses.
Should be taken with food.
Special Precautions
Gynaecological assessment is recommended on long-term treatment. Assess for peptic ulceration in acromegalic patient prior to treatment. History of psychotic disorders or severe CV disease. Pregnancy.
Adverse Reactions
Nausea, postular hypotension, dizziness, headache, vomiting & mild constipation.
ATC Classification
G02CB01 - bromocriptine ; Belongs to the class of prolactine inhibitors. Used to suppress lactation.
Syntocriptine tab 2.5 mg
10 × 10's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in